HOOKIPA Pharma Inc Sustainability Reports
HOOKIPA Pharma Inc. is a biopharmaceutical company that focuses on developing immunotherapies designed to mobilize and amplify T cells to treat cancers and other serious diseases. The company builds its pipelines utilizing its proprietary arenavirus vector platform.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
3 reports from 2020 to 2023
Company Profile
HOOKIPA Pharma Inc. is a biopharmaceutical company that focuses on developing immunotherapies designed to mobilize and amplify T cells to treat cancers and other serious diseases. The company builds its pipelines utilizing its proprietary arenavirus vector platform.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
